We are live on
!
Find out more
HPCM
High Pointe Capital Management Portfolio holdings
AUM
$139M
1-Year Est. Return
24.99%
This Fund
S&P 500
This Quarter
Est. Return
+13.85%
1 Year Est. Return
+24.99%
3 Year Est. Return
+92.38%
5 Year Est. Return
+133.03%
10 Year Est. Return
–
AUM
$106M
AUM Growth
+$23.2M
(+28%)
Cap. Flow
+$12M
Cap. Flow
% of AUM
11.35%
Top 10 Holdings %
Top 10 Hldgs %
27.31%
Holding
95
New
13
Increased
32
Reduced
21
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$2.08M |
| 2 |
FISV
Fiserv Inc
FISV
|
+$2.03M |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$1.92M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$1.82M |
| 5 |
Intel
INTC
|
+$1.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.5M |
| 2 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$1.49M |
| 3 |
NextEra Energy
NEE
|
+$1.27M |
| 4 |
Agilent Technologies
A
|
+$933K |
| 5 |
JPMorgan Chase
JPM
|
+$877K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.65% |
| 2 | Materials | 15.8% |
| 3 | Healthcare | 14.87% |
| 4 | Technology | 14.68% |
| 5 | Communication Services | 11.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Newmont
NEM
$96.2B
| $3.75M | 3.55% |
62,565
+6,085
| +11% | +$375K |
|
|
2
Johnson & Johnson
JNJ
$640B
| $3.38M | 3.2% |
21,465
+14,105
| +192% | +$2.08M |
|
3
Berkshire Hathaway Class B
BRK.B
$1.1T
| $3.27M | 3.1% |
14,092
+2,432
| +21% | +$536K |
|
4
Alphabet (Google) Class A
GOOGL
$4.12T
| $2.98M | 2.82% |
34,020
+4,900
| +17% | +$412K |
|
5
Charter Communications
CHTR
$17.3B
| $2.97M | 2.81% |
4,489
+459
| +11% | +$292K |
|
|
6
iShares Russell Mid-Cap Growth ETF
IWP
$19.4B
| $2.73M | 2.58% |
26,580
-15,660
| -37% | -$1.49M |
|
7
Arista Networks
ANET
$199B
| $2.58M | 2.44% |
141,840
+12,400
| +10% | +$196K |
|
8
Bristol-Myers Squibb
BMY
$129B
| $2.56M | 2.43% |
41,309
+6,133
| +17% | +$377K |
|
9
Cisco
CSCO
$443B
| $2.39M | 2.26% |
53,414
+33,834
| +173% | +$1.39M |
|
10
Pan American Silver
PAAS
$17.9B
| $2.24M | 2.12% |
64,870
+5,120
| +9% | +$165K |
|
11
Molina Healthcare
MOH
$10.4B
| $2.2M | 2.09% |
10,357
+1,867
| +22% | +$385K |
|
|
FISV
12
Fiserv Inc
FISV
$29.7B
| $2.15M | 2.04% |
+18,880
| New | +$2.03M |
|
|
BNY
13
Bank of New York Mellon
BNY
$103B
| $2.12M | 2.01% |
+49,990
| New | +$1.92M |
|
14
Comcast
CMCSA
$87.3B
| $2.04M | 1.93% |
38,827
+6,437
| +20% | +$308K |
|
15
Jacobs Solutions
J
$16B
| $2.01M | 1.91% |
22,319
+1,470
| +7% | +$125K |
|
|
16
BioMarin Pharmaceuticals
BMRN
$11.9B
| $2.01M | 1.9% |
+22,900
| New | +$1.82M |
|
17
Atmos Energy
ATO
$29.7B
| $1.9M | 1.8% |
19,946
-1,034
| -5% | -$99.7K |
|
|
SCHW
18
Charles Schwab
SCHW
$182B
| $1.85M | 1.76% |
34,965
+7,615
| +28% | +$345K |
|
19
Corteva
CTVA
$60.5B
| $1.81M | 1.72% |
46,772
+1,122
| +2% | +$40.1K |
|
20
HP
HPQ
$26B
| $1.78M | 1.69% |
72,500
+49,700
| +218% | +$1.04M |
|
21
Kinross Gold
KGC
$27.7B
| $1.75M | 1.66% |
238,750
+41,700
| +21% | +$332K |
|
|
22
JPMorgan Chase
JPM
$916B
| $1.75M | 1.66% |
13,774
-7,846
| -36% | -$877K |
|
23
Keurig Dr Pepper
KDP
$42.8B
| $1.75M | 1.65% |
+54,520
| New | +$1.61M |
|
|
24
Intel
INTC
$413B
| $1.72M | 1.63% |
+34,590
| New | +$1.69M |
|
25
Nutrien
NTR
$33.9B
| $1.7M | 1.61% |
35,230
-7,340
| -17% | -$324K |
|
Similar funds
COF
TC
FFA
NWM
KCA
RCM
SIS
MWM
High Pointe Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, High Pointe Capital Management held 95 positions worth $106M, up 28% from $82.4M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
High Pointe Capital Management deployed $12M of net new capital in Q4 2020, opening 13 new positions and adding to 32 existing holdings. Its largest new stake was Fiserv Inc: 18,880 shares worth $2.15M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Materials and Healthcare.
On the sell side, the largest reduction was iShares Russell Mid-Cap Growth ETF, an estimated $1.49M trimmed.
- High Pointe Capital Management's largest Q4 2020 buy was Fiserv Inc: 18,880 shares worth $2.15M.
- High Pointe Capital Management added most to Johnson & Johnson in Q4 2020, an estimated $2.08M increase.
- High Pointe Capital Management's biggest Q4 2020 reduction was iShares Russell Mid-Cap Growth ETF, cutting an estimated $1.49M.
- High Pointe Capital Management fully exited AstraZeneca in Q4 2020, selling an estimated $1.5M.
- High Pointe Capital Management's ten largest holdings make up 27% of its $106M portfolio in Q4 2020.
- High Pointe Capital Management opened 13 new positions and closed 10 in Q4 2020.
- High Pointe Capital Management's portfolio value rose 28% quarter-over-quarter to $106M.
Based on High Pointe Capital Management's 13F filing for Q4 2020, filed 8 Feb 2021.